Compare $GTBP vs $SYBX | Chartloom

Compare

$GTBP vs $SYBX

GT Biopharma Inc · Synlogic Inc

GTBP

GT Biopharma Inc

SYBX

Synlogic Inc

Compare $GTBP vs $SYBX

Comparing GT Biopharma Inc and Synlogic Inc

GTBPGT Biopharma Inc

SYBXSynlogic Inc

GTBPGT Biopharma Inc

Market cap

$296M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.3%

52W performance

-75.3%

FCF yield

-4.9%

SYBXSynlogic Inc

Market cap

$13M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-6.0%

52W performance

-24.7%

FCF yield

-28.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GTBP

SYBX

Detailed metrics comparison

GTBP

GT Biopharma Inc

SYBX

Synlogic Inc

Market Cap

GTBP$296M

SYBX$13M

Enterprise Value

GTBP$291M

SYBX$292K

Price

GTBP$6.68

SYBX$1.10

P/E Ratio

GTBPN/A

SYBXN/A

P/S Ratio

GTBP174.71x

SYBX4.20x

EV/Sales

GTBP95.98x

SYBX0.09x

EV/EBITDA

GTBP0.00x

SYBX0.00x

P/B Ratio

GTBP3.08x

SYBX1.12x

P/FCF Ratio

GTBPN/A

SYBXN/A

EV/FCF

GTBP-20.19x

SYBX-0.08x

PEG Ratio

GTBPN/A

SYBXN/A

Forward P/E (NTM)

GTBPN/A

SYBXN/A

Forward P/S (NTM)

GTBPN/A

SYBXN/A

Revenue (TTM)

GTBP$0

SYBX$0

Revenue Growth (YoY)

GTBPN/A

SYBXN/A

Forward Rev Growth

GTBP216.5%

SYBX0.0%

Gross Margin (TTM)

GTBP36.5%

SYBX0.0%

Operating Margin (TTM)

GTBP0.0%

SYBX0.0%

EBITDA Margin (TTM)

GTBP0.0%

SYBX0.0%

Net Margin (TTM)

GTBP0.0%

SYBX0.0%

FCF Margin (TTM)

GTBPN/A

SYBXN/A

Net Income (TTM)

GTBP$-33M

SYBX$-655K

FCF (TTM)

GTBP$-14M

SYBX$-4M

EPS (TTM)

GTBP-$21.10

SYBX-$0.05

ROE (TTM)

GTBP-44308.0%

SYBX-560.0%

ROA (TTM)

GTBP-31311.0%

SYBX-436.0%

ROIC (TTM)

GTBP-44308.0%

SYBX-560.0%

Cash

GTBP$5M

SYBX$13M

Debt

GTBP$0

SYBX$0

Net Cash/Debt

GTBP$5M

SYBX$13M

Current Ratio (TTM)

GTBP2.61x

SYBX9.19x

Quick Ratio (TTM)

GTBP2.51x

SYBX9.05x

Debt/Equity (TTM)

GTBP0.00x

SYBX0.00x

Debt/Assets (TTM)

GTBP0.0%

SYBX0.0%

Interest Coverage (TTM)

GTBPN/A

SYBXN/A

Net Debt/EBITDA (TTM)

GTBP0.00x

SYBX0.00x

Beta

GTBP0.81

SYBX0.87

52W Performance

GTBP-75.3%

SYBX-24.7%

YTD Performance

GTBP-67.3%

SYBX-6.0%

% from 52W High

GTBP-76.8%

SYBX-41.2%

% from 52W Low

GTBP36.0%

SYBX103.7%

Asset Turnover (TTM)

GTBP0.08x

SYBX0.05x

FCF Yield (TTM)

GTBP-4.9%

SYBX-28.5%

Earnings Yield (TTM)

GTBP-11.1%

SYBX-4.9%

Dividend Yield (TTM)

GTBPN/A

SYBXN/A

Rule of 40

GTBP0.0

SYBX0.0

EV/GP/RG

GTBPN/A

SYBXN/A

Ticker research

View GTBP research View SYBX research

Metric	GTBP GT Biopharma Inc	SYBX Synlogic Inc
Market & Valuation
Market Cap	$296M	$13M
Enterprise Value	$291M	$292K
Price	$6.68	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	174.71x	4.20x
EV/Sales	95.98x	0.09x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.08x	1.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.19x	-0.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	216.5%	0.0%
Profitability
Gross Margin (TTM)	36.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-655K
FCF (TTM)	$-14M	$-4M
EPS (TTM)	-$21.10	-$0.05
ROE (TTM)	-44308.0%	-560.0%
ROA (TTM)	-31311.0%	-436.0%
ROIC (TTM)	-44308.0%	-560.0%
Financial Health
Cash	$5M	$13M
Debt	$0	$0
Net Cash/Debt	$5M	$13M
Current Ratio (TTM)	2.61x	9.19x
Quick Ratio (TTM)	2.51x	9.05x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.81	0.87
52W Performance	-75.3%	-24.7%
YTD Performance	-67.3%	-6.0%
% from 52W High	-76.8%	-41.2%
% from 52W Low	36.0%	103.7%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.05x
FCF Yield (TTM)	-4.9%	-28.5%
Earnings Yield (TTM)	-11.1%	-4.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View GTBP research	View SYBX research

Valuation

P/S Ratio

SYBX

4.20x

GTBP

174.71x

EV/FCF

GTBP

-20.19x

SYBX

-0.08x

Growth & revenue

Forward Revenue Growth

GTBP

216.5%

SYBX

0.0%

Profitability & performance

Gross Margin

GTBP

36.5%

SYBX

0.0%

ROE

SYBX

-560.0%

GTBP

-44308.0%

FCF Yield %

GTBP

-4.9%

SYBX

-28.5%

52-Week Performance

SYBX

-24.7%

GTBP

-75.3%

Detailed metrics comparison

GTBP

GT Biopharma Inc

SYBX

Synlogic Inc

Market Cap

GTBP$296M

SYBX$13M

Enterprise Value

GTBP$291M

SYBX$292K

Price

GTBP$6.68

SYBX$1.10

P/E Ratio

GTBPN/A

SYBXN/A

P/S Ratio

GTBP174.71x

SYBX4.20x

EV/Sales

GTBP95.98x

SYBX0.09x

EV/EBITDA

GTBP0.00x

SYBX0.00x

P/B Ratio

GTBP3.08x

SYBX1.12x

P/FCF Ratio

GTBPN/A

SYBXN/A

EV/FCF

GTBP-20.19x

SYBX-0.08x

PEG Ratio

GTBPN/A

SYBXN/A

Forward P/E (NTM)

GTBPN/A

SYBXN/A

Forward P/S (NTM)

GTBPN/A

SYBXN/A

Revenue (TTM)

GTBP$0

SYBX$0

Revenue Growth (YoY)

GTBPN/A

SYBXN/A

Forward Rev Growth

GTBP216.5%

SYBX0.0%

Gross Margin (TTM)

GTBP36.5%

SYBX0.0%

Operating Margin (TTM)

GTBP0.0%

SYBX0.0%

EBITDA Margin (TTM)

GTBP0.0%

SYBX0.0%

Net Margin (TTM)

GTBP0.0%

SYBX0.0%

FCF Margin (TTM)

GTBPN/A

SYBXN/A

Net Income (TTM)

GTBP$-33M

SYBX$-655K

FCF (TTM)

GTBP$-14M

SYBX$-4M

EPS (TTM)

GTBP-$21.10

SYBX-$0.05

ROE (TTM)

GTBP-44308.0%

SYBX-560.0%

ROA (TTM)

GTBP-31311.0%

SYBX-436.0%

ROIC (TTM)

GTBP-44308.0%

SYBX-560.0%

Cash

GTBP$5M

SYBX$13M

Debt

GTBP$0

SYBX$0

Net Cash/Debt

GTBP$5M

SYBX$13M

Current Ratio (TTM)

GTBP2.61x

SYBX9.19x

Quick Ratio (TTM)

GTBP2.51x

SYBX9.05x

Debt/Equity (TTM)

GTBP0.00x

SYBX0.00x

Debt/Assets (TTM)

GTBP0.0%

SYBX0.0%

Interest Coverage (TTM)

GTBPN/A

SYBXN/A

Net Debt/EBITDA (TTM)

GTBP0.00x

SYBX0.00x

Beta

GTBP0.81

SYBX0.87

52W Performance

GTBP-75.3%

SYBX-24.7%

YTD Performance

GTBP-67.3%

SYBX-6.0%

% from 52W High

GTBP-76.8%

SYBX-41.2%

% from 52W Low

GTBP36.0%

SYBX103.7%

Asset Turnover (TTM)

GTBP0.08x

SYBX0.05x

FCF Yield (TTM)

GTBP-4.9%

SYBX-28.5%

Earnings Yield (TTM)

GTBP-11.1%

SYBX-4.9%

Dividend Yield (TTM)

GTBPN/A

SYBXN/A

Rule of 40

GTBP0.0

SYBX0.0

EV/GP/RG

GTBPN/A

SYBXN/A

Ticker research

View GTBP research View SYBX research

Metric	GTBP GT Biopharma Inc	SYBX Synlogic Inc
Market & Valuation
Market Cap	$296M	$13M
Enterprise Value	$291M	$292K
Price	$6.68	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	174.71x	4.20x
EV/Sales	95.98x	0.09x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.08x	1.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.19x	-0.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	216.5%	0.0%
Profitability
Gross Margin (TTM)	36.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-655K
FCF (TTM)	$-14M	$-4M
EPS (TTM)	-$21.10	-$0.05
ROE (TTM)	-44308.0%	-560.0%
ROA (TTM)	-31311.0%	-436.0%
ROIC (TTM)	-44308.0%	-560.0%
Financial Health
Cash	$5M	$13M
Debt	$0	$0
Net Cash/Debt	$5M	$13M
Current Ratio (TTM)	2.61x	9.19x
Quick Ratio (TTM)	2.51x	9.05x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.81	0.87
52W Performance	-75.3%	-24.7%
YTD Performance	-67.3%	-6.0%
% from 52W High	-76.8%	-41.2%
% from 52W Low	36.0%	103.7%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.05x
FCF Yield (TTM)	-4.9%	-28.5%
Earnings Yield (TTM)	-11.1%	-4.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View GTBP research	View SYBX research